Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Cti Biopharm Corp (NASDAQ: CTIC)

$4.16 USD -$0.21 (-4.81%)
Last Price $4.16
Net Change $-0.21 (-4.81%)
Bid $4.16
Ask Price $5.07
Open Price $4.42
Previous Close Price $4.37
High Price $4.42
Low Price $4.15
Number of Trades 632
Volume 179,180
Fifty Two Week High $6.48 (2017-01-09)
Fifty Two Week Low $3.1 (2016-06-27)
Average Daily Volume 252,366
Share Outstanding 28,230 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-61.29
Recent Earnings $
Annual EPS $-1.83
Last Quarter EPS $
Market Capitalization $0.12B
Insider Shareholders % 0.0301%
Annual Revenue $0B
No. Shares Outstanding 28,230
Inst. Shareholder % 0%
Annual Net Income $-0.05B
TTM Net Profit Margin $-90.59
1-Year Return -12.6%
3-Year Return -87.15%
5-Year Return -93.33%
5-Year Revenue Growth 0%
5-Year Earnings Growth -95.17%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -61.290001%
Dividends per Share $
Stock Split Ratio 1-10
Beta 0.8
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe and on continuing the development of its late-stage development pipeline including pacritinib. CTI BioPharma Corp. formerly known as Cell Therapeutics Inc. is headquartered in Seattle Washington.

CTIC News & Stock Updates